[Therapy of ischemic heart disease with Trapidil. Observations with 4,014 patients in medical practice]

Within the framework of a user observations study, 4,014 patients with ischemic heart disease were treated with Trapidil and kept under observation for 12 weeks.

During the course of therapy, a decrease in the incidence and intensity of attacks of angina pectoris and in the number of weekly short-term nitrate applications was observed. Side effects, most commonly nausea, headache, GI complaints and giddiness, were reported by only 3.8% of the patients. The efficacy of the preparation was assessed to be good or very good in more than 89%, tolerability in more than 90%, of the cases. These results are in accord with the assessment in reports in the international literature to the effect that Trapidil has a good therapeutic action.